| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1693 | 2015 |
| Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA … PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ... The Lancet Neurology 8 (7), 619-627, 2009 | 744 | 2009 |
| Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 394 | 2019 |
| Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 180 | 2018 |
| Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment I Ramakers, FRJ Verhey, P Scheltens, H Hampel, H Soininen, P Aalten, ... Psychological medicine 43 (5), 911-920, 2013 | 165 | 2013 |
| Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study IS van Maurik, SJ Vos, I Bos, FH Bouwman, CE Teunissen, P Scheltens, ... The Lancet Neurology 18 (11), 1034-1044, 2019 | 128 | 2019 |
| Do Instrumental Activities of Daily Living Predict Dementia at 1‐and 2‐Year Follow‐Up? Findings from the Development of Screening Guidelines and Diagnostic Criteria for … SAM Sikkes, PJ Visser, DL Knol, ESM de Lange‐de Klerk, M Tsolaki, ... Journal of the American Geriatrics Society 59 (12), 2273-2281, 2011 | 102 | 2011 |
| Development of screening guidelines and clinical criteria for predementia Alzheimer’s disease: the DESCRIPA Study PJ Visser, FRJ Verhey, M Boada, R Bullock, PP De Deyn, GB Frisoni, ... Neuroepidemiology 30 (4), 254-265, 2008 | 98 | 2008 |
| Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease N Mattsson, C Groot, WJ Jansen, SM Landau, VL Villemagne, ... Alzheimer's & Dementia 14 (7), 913-924, 2018 | 89 | 2018 |
| Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the European prospective DESCRIPA study M Damian, L Hausner, K Jekel, M Richter, L Froelich, O Almkvist, ... Dementia and geriatric cognitive disorders 36 (1-2), 1-19, 2013 | 63 | 2013 |
| Progression of Alzheimer disease in Europe: data from the European ICTUS study B Vellas, L Hausner, L Frolich, C Cantet, V Gardette, E Reynish, S Gillette, ... Current Alzheimer Research 9 (8), 902-912, 2012 | 63 | 2012 |
| Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial B Dubois, J López-Arrieta, S Lipschitz, T Doskas, L Spiru, S Moroz, ... Alzheimer's Research & Therapy 15 (1), 39, 2023 | 62 | 2023 |
| Characteristics of subjective cognitive decline associated with amyloid positivity O Janssen, WJ Jansen, SJB Vos, M Boada, L Parnetti, T Gabryelewicz, ... Alzheimer's & Dementia 18 (10), 1832-1845, 2022 | 45 | 2022 |
| Association between later life lifestyle factors and Alzheimer’s disease biomarkers in non-demented individuals: a longitudinal descriptive cohort study BLR Reijs, SJB Vos, H Soininen, J Lötjonen, J Koikkalainen, ... Journal of Alzheimer’s Disease 60 (4), 1387-1395, 2017 | 41 | 2017 |
| The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study P Bosco, A Redolfi, M Bocchetta, C Ferrari, A Mega, S Galluzzi, M Austin, ... Alzheimer's & Dementia 13 (9), 1013-1023, 2017 | 39 | 2017 |
| Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey KS Frederiksen, TR Nielsen, I Appollonio, BB Andersen, M Riverol, ... International Journal of Geriatric Psychiatry 36 (2), 324-333, 2021 | 31 | 2021 |
| DNMT3A Moderates Cognitive Decline in Subjects with Mild Cognitive Impairment: Replicated Evidence from Two Mild Cognitive Impairment Cohorts L Chouliaras, G Kenis, PJ Visser, P Scheltens, M Tsolaki, RW Jones, ... Epigenomics 7 (4), 533-537, 2015 | 31 | 2015 |
| Regional Differences in Effects of APOE ε4 on Cognitive Impairment in Non-Demented Subjects J Norberg, C Graff, O Almkvist, M Ewers, GB Frisoni, L Frölich, H Hampel, ... Dementia and geriatric cognitive disorders 32 (2), 135-142, 2011 | 23 | 2011 |
| Distinctive under-expression profile of inflammatory and redox genes in the blood of elderly patients with cardiovascular disease E Milanesi, G Manda, M Dobre, E Codrici, IV Neagoe, BO Popescu, ... Journal of Inflammation Research, 429-442, 2021 | 17 | 2021 |
| A longitudinal study of transitions between informal and formal care in Alzheimer disease using multistate models in the European ICTUS cohort N Coley, A Gallini, V Gares, V Gardette, S Andrieu, B Vellas, E Reynish, ... Journal of the American Medical Directors Association 16 (12), 1104. e1-1104. e7, 2015 | 15 | 2015 |
